The global women health diagnostics market is anticipated to grow significantly at a CAGR of 7.9% during the forecast period. The primary factor which is bolstering the growth of the market is the rise in various technological advancements in medical diagnostic devices across the globe. The advancement in diagnostics technology and increasing the demand for testing, therapies, and devices of such as sonograms for pregnancy, fluoroscopy/radiography, breast imaging, and magnetic resonance imaging (MRI). Several healthcare companies use disruptive technology including machine learning, artificial intelligence (AI), big data, and the internet of things (IoT) to develop digital health applications for women’s health.
Browse the full report description of “Global Women Health Diagnostics Market Size, Share & Trends Analysis Report by Application (Breast Cancer Testing, Cervical Cancer Testing, Pregnancy & Fertility Testing, Ovarian Cancer Testing, Infectious Disease Testing, Ultrasound Tests, Sexually Transmitted Disease Testing, and Others), and by End-Users (Diagnostic and Imaging Centers, Hospitals and Clinics, and Home Care) Forecast Period (2022-2028)” at https://www.omrglobal.com/industry-reports/womens-health-diagnostics-market-size
For instance, in June 2021, Max Healthcare launched AI-powered devices integrated patient monitoring framework. Max Healthcare has launched the service in collaboration with digital health solutions provider MyHealthcare. Patients can use the platform Max MyHealth to monitor their vitals with clinical devices integrated into the app, allowing clinical readings to flow seamlessly from the device into the app and the electronic medical records (EMR), for the doctor's review. The Max MyHealth+ ecosystem, built-in in collaboration with MyHealthcare, has integrated blood pressure monitors, ECG, and heart rate devices, and blood sugar monitoring devices.
Further, in October 2020, Tencent launched AI-powered medical imaging and data management devices at China International Medical Device Expo (CMEF). Through this product launch, the company aims to enable consumers and medical professionals to safely and securely share medical data more easily, and equip medical professionals new tools to diagnose patients and achieve better patient outcomes.
Market Coverage
• The market number available for – 2021-2028
• Base year- 2021
• Forecast period- 2022-2028
• Segment Covered-
o By Application
o By End-Users
• Regions Covered- North America, Europe, Asia-Pacific, Rest of the World
• Competitive Landscape- Trinity Biotech PLC, Thermo Fisher Scientific Inc., Somagen Diagnostics Inc., Siemens AG, Quest Diagnostics Inc., and others.
Key questions addressed by the report
• What is the market growth rate?
• Which segment/region dominates the market in the base year?
• Which segment/region will project the fastest growth in the market?
• How has COVID-19 impacted the market?
o Recovery Timeline
o Deviation from the pre-COVID forecast
o Most affected region/segment
• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?
Global Women Health Diagnostics Market– Segmentation
By Application
By End-Users
Global Women Health Diagnostics Market by Region
North America
• US
• Canada
Europe
• Germany
• United Kingdom
• France
• Spain
• Italy
• Rest of Europe
Asia-Pacific
• China
• Japan
• India
• Rest of Asia-Pacific
Rest of the World
• Middle East & Africa
• Latin America
To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/womens-health-diagnostics-market-size